GAM Holding AG Has $13.67 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAM Holding AG decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 26,191 shares of the medical equipment provider’s stock after selling 13,490 shares during the quarter. Intuitive Surgical accounts for about 1.0% of GAM Holding AG’s investment portfolio, making the stock its 26th biggest position. GAM Holding AG’s holdings in Intuitive Surgical were worth $13,671,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Kornitzer Capital Management Inc. KS raised its stake in shares of Intuitive Surgical by 0.7% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 5,814 shares of the medical equipment provider’s stock valued at $3,035,000 after purchasing an additional 39 shares in the last quarter. Venturi Wealth Management LLC raised its stake in shares of Intuitive Surgical by 21.5% in the 4th quarter. Venturi Wealth Management LLC now owns 1,642 shares of the medical equipment provider’s stock valued at $857,000 after buying an additional 291 shares in the last quarter. D.A. Davidson & CO. lifted its holdings in shares of Intuitive Surgical by 0.9% during the 4th quarter. D.A. Davidson & CO. now owns 13,198 shares of the medical equipment provider’s stock worth $6,889,000 after acquiring an additional 115 shares during the period. Truist Financial Corp boosted its position in shares of Intuitive Surgical by 3.0% during the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider’s stock valued at $129,494,000 after acquiring an additional 7,298 shares in the last quarter. Finally, Catalyst Capital Advisors LLC increased its stake in Intuitive Surgical by 132.5% in the fourth quarter. Catalyst Capital Advisors LLC now owns 637 shares of the medical equipment provider’s stock valued at $332,000 after acquiring an additional 363 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Piper Sandler restated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. CICC Research assumed coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Bernstein Bank increased their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Truist Financial lifted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Finally, Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Up 0.7 %

Shares of ISRG opened at $595.55 on Tuesday. The firm has a market capitalization of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock’s fifty day simple moving average is $559.48 and its 200-day simple moving average is $520.19.

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.